Search - tctmd.com

Displaying 21 - 40 of 318

Sort: Relevancy | Date

Presentation NY Valves 2024

Debate Con: Echo First and Only to Diagnose Bioprosthetic Valve Dysfunction /Failure

Presenter: Rebecca T. Hahn

June 06, 2024

Presentation NY Valves 2024

Mid-term outcomes of balloon expandable TAVR: do gradients and gender matter?

Presenter: Rebecca T. Hahn

June 06, 2024

Presentation NY Valves 2024

Echocardiographic Characterization

Presenter: Rebecca T. Hahn

June 05, 2024

News Conference News NY Valves 2024

Reassuring 5-Year Outcomes for Sapien-Treated TAVI Patients With Small Annuli

Michael O'Riordan

June 05, 2024

Presentation NY Valves 2024

Late Clinical Outcomes With Balloon Expandable Valves in Small Annulus Patients From the PARTNER Trials

Presenter: Rebecca T. Hahn

June 05, 2024

News Conference News ACC 2024

SMART: Small Aortic Annuli May Fare Best With Self-Expandable Valve

L.A. McKeown

April 07, 2024

Presentation THT 2024

A Heart Team Approach to Management of TR in Patients With Cardiac Implantable Electronic Device Leads (CEIDs)

Presenter: Rebecca T. Hahn

March 04, 2024

News Daily News

FDA Approves First Transcatheter Tricuspid Valve Replacement Device

L.A. McKeown

February 02, 2024

News Conference News TCT 2023

MitraClip G4 Data Impress, but Some Question the Reproducibility: EXPAND G4

Yael L. Maxwell

November 02, 2023

News Conference News TCT 2023

Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3

Michael O'Riordan

November 01, 2023

Presentation TCT 2023

Echo Evaluation First

Presenter: Rebecca Hahn

October 26, 2023

Presentation TCT 2023

Anatomic Eligibility Criteria for Tricuspid Transcatheter Edge-to-Edge Repair: Ideal to Contraindicated

Presenter: Rebecca Hahn

October 26, 2023

Presentation TCT 2023

What We Now Know About Tricuspid Regurgitation Outcomes: Differences in Natural History Based on Etiology

Presenter: Rebecca Hahn

October 26, 2023

News Conference News TCT 2023

ALIGN-AR: Positive Results for Trilogy Valve in Aortic Regurgitation

Todd Neale

October 26, 2023

News Conference News TCT 2023

More TRILUMINATE Patients Flesh Out Tricuspid TEER’s Impact

Yael L. Maxwell

October 24, 2023

Presentation TCT 2023

Five-year Echocardiographic Outcomes From The PARTNER 3 Low-risk Randomized Trial

Presenter: Rebecca Hahn

October 24, 2023

Presentation TVT 2023

Procedural Considerations: When We Should and Shouldn't Remove the Lead First?

Presenter: Rebecca Hahn

June 09, 2023

Presentation TVT 2023

Assessment of Right Heart Function in Severe TR - Implications for Therapy Selection

Presenter: Rebecca Hahn

June 08, 2023

Presentation TVT 2023

Integrating Tricuspid Anatomy With Imaging

Presenter: Rebecca Hahn

June 08, 2023

Presentation THT 2023

TR in the Modern Era: Natural History, Pathoanatomy, and Imaging

Presenter: Rebecca Hahn

March 22, 2023

Advertisement

Debate Con: Echo First and Only to Diagnose Bioprosthetic Valve Dysfunction /Failure

Mid-term outcomes of balloon expandable TAVR: do gradients and gender matter?

Echocardiographic Characterization

Reassuring 5-Year Outcomes for Sapien-Treated TAVI Patients With Small Annuli

Late Clinical Outcomes With Balloon Expandable Valves in Small Annulus Patients From the PARTNER Trials

SMART: Small Aortic Annuli May Fare Best With Self-Expandable Valve

A Heart Team Approach to Management of TR in Patients With Cardiac Implantable Electronic Device Leads (CEIDs)

FDA Approves First Transcatheter Tricuspid Valve Replacement Device

MitraClip G4 Data Impress, but Some Question the Reproducibility: EXPAND G4

Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3

Echo Evaluation First

Anatomic Eligibility Criteria for Tricuspid Transcatheter Edge-to-Edge Repair: Ideal to Contraindicated

What We Now Know About Tricuspid Regurgitation Outcomes: Differences in Natural History Based on Etiology

ALIGN-AR: Positive Results for Trilogy Valve in Aortic Regurgitation

More TRILUMINATE Patients Flesh Out Tricuspid TEER’s Impact

Five-year Echocardiographic Outcomes From The PARTNER 3 Low-risk Randomized Trial

Procedural Considerations: When We Should and Shouldn't Remove the Lead First?

Assessment of Right Heart Function in Severe TR - Implications for Therapy Selection

Integrating Tricuspid Anatomy With Imaging

TR in the Modern Era: Natural History, Pathoanatomy, and Imaging

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content